CardioVascular BioTherapeutics (fka CVBT)

[walhall]

If the patents had any value whatsoever (and they don't), why did Venturis's own law firm--the one that all but certainly filed the IP and certainly knows what the patents are--state to the U.S. Federal Court, "Upon investigation as to Venturis ability to pay legal fees in accordance with its agreement, it has become evident that there are currently no assets or revenue streams from which payments can be made"?

Venturis's own law firm is publicly stating that they believe these patents are worthless--which happens to also be the opinion of anyone qualified who is not a part of the company's leadership team.

If the patents had any value whatsoever, why wouldn't Dentons have gone after them for payment of its $200,000+ in unpaid invoices?